Related Experiment Video
Updated: Jul 5, 2026

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats
Wenli Lv1, Jianxin Guo, Qineng Ping
1School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Aim:
To compare pharmacokinetics of intravenous breviscapine liposomes in Beagle dogs, rabbits and rats.
Methods:
Six Beagle dogs, 6 rabbits and 12 rats were intravenously administrated with breviscapine liposomes and commercial injection (breviscapine solution) by the crossover design (two periods), respectively. Plasma concentration of scutellarin, the main active component in breviscapine, at different time intervals was determined by reverse phase-HPLC. The pharmacokinetic parameters including area under the curve (AUC), clearance (CL(s)) and volume of distribution (V(c)) were calculated.
Results:
The plasma concentration-time profiles were fitted to a two-compartment model. Breviscapine liposomes exhibited significant difference from injection in CL((s)) and AUC, examined by a one-way analysis of variance (ANOVA). With regard to both breviscapine liposomes and commercial injection (free breviscapine), the logarithm values of AUC, CL(s) and V(c) were all related to the logarithm of the body weight by the allometric equation: Y=axW(b).
Conclusion:
The allometric equation might be applied to extroplate dosage for human from animal data and also for dosage adjustment of breviscapine liposomes in order to achieve same AUC as commercial injection. Compared with the breviscapine solution, breviscapine liposomes delivered more scutellarin into the plasma.
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Modified-Release Drug Delivery Systems: Bioavailability
Measurement of Bioavailability: Pharmacodynamic Methods
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Measurement of Bioavailability: Pharmacokinetic Methods
Bioavailability Study Design: Single Versus Multiple Dose Studies

